BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

CLEARANT INC — Lobbying — Receipts Report

LD-2 disclosure · 1st Quarter - Report

CLEARANT INC

via MCDERMOTT WILL & SCHULTE LLP

1st Quarter (Jan 1 - Mar 31) · 2012Posted Apr 20, 2012Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: CLEARANT INC
Description: Health Care, Biological Science, Regulatory Affairs
Location: Florida · United States of America

Registrant

Firm: MCDERMOTT WILL & SCHULTE LLP
Description: Law Firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
Tissue regulation and legislation
LobbyistsERICA STOCKER · TEDDY EYNON
Covered position (ERICA STOCKER): Saxton
Covered position (TEDDY EYNON): and Oversight Committee
TargetedSENATE · HOUSE OF REPRESENTATIVES · Food & Drug Administration (FDA)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.